comparemela.com

Latest Breaking News On - Hiron financial - Page 6 : comparemela.com

IRON Financial LLC Makes New Investment in AmerisourceBergen Co (NYSE:ABC)

IRON Financial LLC purchased a new position in AmerisourceBergen Co. (NYSE:ABC – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,476 shares of the company’s stock, valued at approximately $717,000. Other hedge funds have also modified their holdings of the […]

The Clorox Company (NYSE:CLX) Shares Sold by IRON Financial LLC

IRON Financial LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 11.3% during the first quarter, HoldingsChannel reports. The institutional investor owned 5,590 shares of the company’s stock after selling 712 shares during the quarter. IRON Financial LLC’s holdings in Clorox were worth $885,000 at the end of the […]

IRON Financial LLC Has $210,000 Stock Position in Packaging Co of America (NYSE:PKG)

IRON Financial LLC cut its position in shares of Packaging Co. of America (NYSE:PKG – Free Report) by 73.1% during the 1st quarter, Holdings Channel reports. The firm owned 1,516 shares of the industrial products company’s stock after selling 4,125 shares during the quarter. IRON Financial LLC’s holdings in Packaging Co. of America were worth […]

Direxion Auspice Broad Commodity Strategy ETF (NYSEARCA:COM) Stock Holdings Cut by IRON Financial LLC

IRON Financial LLC reduced its position in shares of Direxion Auspice Broad Commodity Strategy ETF (NYSEARCA:COM – Free Report) by 5.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,081 shares of the company’s stock after selling 491 shares during the quarter. […]

IRON Financial LLC Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)

IRON Financial LLC bought a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,123 shares of the biopharmaceutical company’s stock, valued at approximately $702,000. Several other hedge funds have also made […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.